tiprankstipranks
Mankind Pharma Ltd. (IN:MANKIND)
:MANKIND
India Market
MANKIND
Mankind Pharma Ltd.
RESEARCH TOOLSreports

Mankind Pharma Ltd. (MANKIND) Income Statement

13 Followers

Mankind Pharma Ltd. Income Statement

Last quarter (Q2 2026), Mankind Pharma Ltd.'s total revenue was ₹36.97B, an increase of 20.77% from the same quarter last year. In Q2, Mankind Pharma Ltd.'s net income was ₹5.12B. See Mankind Pharma Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 122.07B₹ 102.59B₹ 87.49B₹ 77.82B₹ 62.14B
Gross Profit
₹ 86.38B₹ 70.02B₹ 57.87B₹ 53.12B₹ 43.89B
Operating Expenses
₹ 61.22B₹ 47.63B₹ 41.45B₹ 34.28B₹ 27.83B
Depreciation and Amortization
₹ 6.21B₹ 3.78B₹ 3.26B₹ 1.67B₹ 1.19B
EBITDA
₹ 35.58B₹ 28.04B₹ 20.37B₹ 21.97B₹ 18.30B
Operating Income
₹ 25.16B₹ 22.39B₹ 16.42B₹ 18.84B₹ 16.06B
Other Income/Expenses
₹ 5.00M₹ 1.59B₹ 296.23M₹ 909.65M₹ 851.50M
Pretax Income
₹ 25.16B₹ 23.98B₹ 16.71B₹ 19.75B₹ 16.92B
Net Income
₹ 19.91B₹ 19.13B₹ 12.82B₹ 14.33B₹ 12.65B
Per Share Metrics
Basic EPS
₹ 49.17₹ 47.75₹ 32.00₹ 35.78₹ 31.59
Diluted EPS
₹ 49.09₹ 47.68₹ 32.00₹ 35.78₹ 31.59
Weighted Average Shares Outstanding
 404.67M 400.59M 400.59M 400.59M 400.59M
Weighted Average Shares Outstanding (Diluted)
 404.67M 401.17M 400.59M 400.59M 400.59M
Currency in INR

Mankind Pharma Ltd. Earnings and Revenue History